日本語 
Pharma
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…
Hitachi and Shionogi deploy genAI in drug regulatory work
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astella and Vir Biotechnology sign global deal for VIR-5500
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine
Japan is at the forefront of healthcare innovation by becoming the first…
Q-Sera Launches RAPClot Blood Collection Tubes in Japan, Marking Breakthrough in Diagnostic Efficiency
Australian diagnostics innovator Q, Sera Pty Ltd has announced that its patented…
Emeraid and Integrity Healthcare finish clinical data project
Emeraid Inc., a healthcare AI DX startup originating from the University of…
B-MAP and Ignis Explore Medical-Skynet AI for Clinics
B-MAP Inc. is pleased to announce that it has today signed a…
Eisai and Henlius Sign Japan Rights Deal for Serplulimab
Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…
Rakuten Medical and LOTTE Biologics Forge Strategic Manufacturing Alliance to Fuel Global Oncology Programs
Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…
English